Literature DB >> 10452537

The sensitivity of versican from rabbit lung to gelatinase A (MMP-2) and B (MMP-9) and its involvement in the development of hydraulic lung edema.

A Passi1, D Negrini, R Albertini, G Miserocchi, G De Luca.   

Abstract

Large chondroitinsulphate-containing proteoglycan (versican) isolated from rabbit lung was cleaved by purified gelatinase A (MMP-2) and gelatinase B (MMP-9), as well as by crude enzyme extract from rabbit lung with hydraulic edema. Gelatine zymography, performed after purification of gelatinases by affinity chromatography, demonstrated that the enzyme extract contained two main gelatinolytic bands at about 92 kDa and 72 kDa, identified by specific antisera as the latent proMMP-9 and proMMP-2, respectively. Moreover, enzyme extract from edematous lung showed an increased amount of the proteolytically activated forms of both gelatinases with respect to normal controls. These results suggest that MMP-2 and MMP-9 are involved in the breakdown of versican occurring in rabbit lung during the development of hydraulic edema.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10452537     DOI: 10.1016/s0014-5793(99)00929-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  24 in total

1.  Proteolytic cleavage of versican during cardiac cushion morphogenesis.

Authors:  Christine B Kern; Waleed O Twal; Corey H Mjaatvedt; Sarah E Fairey; Bryan P Toole; M Luisa Iruela-Arispe; W Scott Argraves
Journal:  Dev Dyn       Date:  2006-08       Impact factor: 3.780

2.  Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression.

Authors:  Elaine L Shelton; Katherine E Yutzey
Journal:  Dev Biol       Date:  2006-10-03       Impact factor: 3.582

3.  Versican proteolysis mediates myocardial regression during outflow tract development.

Authors:  Christine B Kern; Russell A Norris; Robert P Thompson; W Scott Argraves; Sarah E Fairey; Leticia Reyes; Stanley Hoffman; Roger R Markwald; Corey H Mjaatvedt
Journal:  Dev Dyn       Date:  2007-03       Impact factor: 3.780

Review 4.  The role of proteoglycans in pulmonary edema development.

Authors:  Daniela Negrini; Alberto Passi; Andrea Moriondo
Journal:  Intensive Care Med       Date:  2008-02-09       Impact factor: 17.440

5.  Expression and localization of versican during postnatal development of rat temporomandibular joint disc.

Authors:  Naoko Toriya; Taishin Takuma; Toshiya Arakawa; Yoshihiro Abiko; Yasuyuki Sasano; Ichiro Takahashi; Yasunori Sakakura; Firoz Rahemtulla; Itaru Mizoguchi
Journal:  Histochem Cell Biol       Date:  2005-09-27       Impact factor: 4.304

Review 6.  Versican degradation and vascular disease.

Authors:  Richard D Kenagy; Anna H Plaas; Thomas N Wight
Journal:  Trends Cardiovasc Med       Date:  2006-08       Impact factor: 6.677

7.  Proteolytic cleavage of versican and involvement of ADAMTS-1 in VEGF-A/VPF-induced pathological angiogenesis.

Authors:  Yineng Fu; Janice A Nagy; Lawrence F Brown; Shou-Ching Shih; Pamela Y Johnson; Christina K Chan; Harold F Dvorak; Thomas N Wight
Journal:  J Histochem Cytochem       Date:  2011-03-16       Impact factor: 2.479

Review 8.  Versican: A Dynamic Regulator of the Extracellular Matrix.

Authors:  Shamima Islam; Hideto Watanabe
Journal:  J Histochem Cytochem       Date:  2020-09-10       Impact factor: 2.479

9.  Endothelial deletion of ADAM17 in mice results in defective remodeling of the semilunar valves and cardiac dysfunction in adults.

Authors:  Carole L Wilson; Peter J Gough; Cindy A Chang; Christina K Chan; Jeremy M Frey; Yonggang Liu; Kathleen R Braun; Michael T Chin; Thomas N Wight; Elaine W Raines
Journal:  Mech Dev       Date:  2013-01-24       Impact factor: 1.882

10.  Collagens, proteoglycans, MMP-2, MMP-9 and TIMPs in human achilles tendon rupture.

Authors:  Evgenia Karousou; Mario Ronga; Davide Vigetti; Alberto Passi; Nicola Maffulli
Journal:  Clin Orthop Relat Res       Date:  2008-04-19       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.